Cargando…
Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell Migration
Cancer metastasis accounts for most of the mortality associated with solid tumors. However, antimetastatic drugs are not available on the market. One of the important biological events leading to metastasis is the epithelial to mesenchymal transition (EMT) induced by cytokines, namely transforming g...
Autores principales: | Toma, Tsugumasa, Tateishi, Hiroshi, Kawakami, Kensaku, Ali, Taha F. S., Kamo, Masahiro, Monde, Kazuaki, Nakashima, Yuta, Fujita, Mikako, Otsuka, Masami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102712/ https://www.ncbi.nlm.nih.gov/pubmed/35563439 http://dx.doi.org/10.3390/ijms23095047 |
Ejemplares similares
-
New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia
por: Hamdy, Ahmed K., et al.
Publicado: (2022) -
A clue to unprecedented strategy to HIV eradication: “Lock-in and apoptosis”
por: Tateishi, Hiroshi, et al.
Publicado: (2017) -
A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy
por: Özdemir, Ahmet, et al.
Publicado: (2022) -
Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity
por: Ali, Taha F. S., et al.
Publicado: (2022) -
SAMHD1-Dependent and -Independent Functions of HIV-2/SIV Vpx Protein
por: Fujita, Mikako, et al.
Publicado: (2012)